<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04607239</url>
  </required_header>
  <id_info>
    <org_study_id>HTA-TELEMED</org_study_id>
    <nct_id>NCT04607239</nct_id>
  </id_info>
  <brief_title>The Impact of Telemonitoring in the Management of Hypertension</brief_title>
  <acronym>HOROSCOPE</acronym>
  <official_title>HOme telemonitoRing of Arterial hypertensiOn With antihypertenSive Treatment Titration: a Randomized COntrolled prosPEctive Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Les Laboratoires des Médicaments Stériles</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Les Laboratoires des Médicaments Stériles</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Rater blinded, multi-center, prospective, randomized controlled study comparing mean 24 hour&#xD;
      systolic blood pressure of eligible hypertensive patients in the TELEMONITORIN group versus&#xD;
      the USUAL CARE group, at 6 months after inclusion.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 4, 2020</start_date>
  <completion_date type="Anticipated">July 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">July 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>The interventional group (Telemonitoring) in addition to the usual care group (conventional) will benefit from:&#xD;
a weekly telephone call for collection of home Blood Pressure measurements , therapeutic education &amp; treatment compliance check&#xD;
a monthly call for treatment titration and side effects check</intervention_model_description>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mean of 24h systolic blood pressure (SBP)</measure>
    <time_frame>0 - 180 days</time_frame>
    <description>The change from baseline of mean 24-hour systolic blood pressure (SBP) at 6 months of follow-up</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mean of 24h diastolic blood pressure (DBP)</measure>
    <time_frame>0-180 days</time_frame>
    <description>The change from baseline of mean 24 hour diastolic blood pressure (DBP) at 6 months of follow-up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>percentage of blood pressure load</measure>
    <time_frame>0-180 days</time_frame>
    <description>The change of blood pressure load's percentages between baseline and 6 months of follow-up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>percentage of Dipping</measure>
    <time_frame>0-180 days</time_frame>
    <description>The change of dipping percentages between baseline and 6 months of follow-up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean of the Short Form survey (SF-12) scores</measure>
    <time_frame>0-180 days</time_frame>
    <description>The change in the mean of SF-12 scores between baseline and 6 months of follow-up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>frequency of cardiovascular complications</measure>
    <time_frame>180 days</time_frame>
    <description>Clinical outcomes including hospitalization rate, emergency room admissions related to high blood pressure, adverse effects, or other reasons</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">460</enrollment>
  <condition>Health Services Administration</condition>
  <condition>Telemedicine</condition>
  <condition>Hypertension</condition>
  <arm_group>
    <arm_group_label>Telemonitoring</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In addition to the usual care, this group benefits from a weekly telephone call by the Clinical Research Associate (CRA) for the collection of home blood pressure measurements (which the patient measures twice a day everyday), for therapeutic education, and for treatment compliance assessment.&#xD;
This group will also benefit from a monthly call by the attending physician for treatment titration and side effects check.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>This group will benefit form the usual care without any phone calls for therapeutic education, treatment compliance assessment, treatment titration or side effects check.&#xD;
The usual care includes attending the follow up visits after inclusion at Day 90 (D-90) &amp; Day 180 (D-180) for face to face consultation with the attending physician.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Telemonitoring</intervention_name>
    <description>A weekly telephone call by the CRA for the collection of home blood pressure measurements (which the patient measures twice a day everyday), for therapeutic education, and for treatment compliance assessment.&#xD;
A monthly call by the attending physician for treatment titration and side effects check.</description>
    <arm_group_label>Telemonitoring</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Usual Care without Telemonitoring</intervention_name>
    <description>Attending the follow up visits after inclusion at Day 90 (D-90) &amp; Day 180 (D-180) for face to face consultation with the attending physician.&#xD;
Usual care without any phone calls for therapeutic education, treatment compliance assessment, treatment titration or side effects check.</description>
    <arm_group_label>Conventional</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Included are patients with:&#xD;
&#xD;
          -  age ≥ 35 years old&#xD;
&#xD;
          -  newly diagnosed hypertention&#xD;
&#xD;
          -  uncontrolled hypertention&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Excluded are patients with:&#xD;
&#xD;
          -  orthostatic hypotension&#xD;
&#xD;
          -  chronic renal failure (serum creatinine &gt; 200 micromol / L)&#xD;
&#xD;
          -  acute coronary syndrome&#xD;
&#xD;
          -  coronary revascularization or stroke within the past 3 months&#xD;
&#xD;
          -  known secondary causes of hypertension&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  New York Heart Association Class III or IV heart failure or left ventricular ejection&#xD;
             fraction &lt; 30%&#xD;
&#xD;
          -  dementia or another cause that prevents the application of remote monitoring&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Semir NOUIRA, Prof</last_name>
    <phone>0021673106085</phone>
    <email>semir.nouira@rns.tn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sonia BEN HAFAIEDH, MD</last_name>
    <phone>0021698709311</phone>
    <email>s.hafaiedh@medis.com.tn</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Fattouma Bourguiba Hospital</name>
      <address>
        <city>Monastir</city>
        <country>Tunisia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Semir NOUIRA, Prof</last_name>
      <phone>0021673106085</phone>
      <email>semir.nouira@rns.tn</email>
    </contact>
  </location>
  <location_countries>
    <country>Tunisia</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>October 22, 2020</study_first_submitted>
  <study_first_submitted_qc>October 22, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 29, 2020</study_first_posted>
  <last_update_submitted>November 20, 2020</last_update_submitted>
  <last_update_submitted_qc>November 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Telecommunication</keyword>
  <keyword>Telecare</keyword>
  <keyword>Teleconsult</keyword>
  <keyword>Telemanagement</keyword>
  <keyword>Telemonitoring</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

